Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India Ltd Share Price Today: Live Updates & Key Insights
Get insights on Sanofi Consumer Healthcare India Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Sanofi Consumer Healthcare India Ltd Share Price Chart
SANOFICONR at 10 Jul 2026 06:33 PM Pharmaceuticals
4566.70 +60.30(+1.34%)
Lowest Today 4505.20
Highest Today 4580.00
Today's Open 4529.00
Prev. Close 4506.40
52 Week High 5894.50
52 Week Low 3975.00
Sanofi Consumer Healthcare India Ltd Fundamentals
Traded Volume: 2,556
Market Cap(Cr): 10,517.39
Avg Traded Price 4552.10
1 Year return -12.48%
Upper Circuit 4,580
Lower Circuit 4,505.2
P/E TTM 41.00
P/B Ratio 0.00
Traded Value(Cr) 116.72
EPS TTM 111.981
Book value/Share NaN
Dividend Yield 1Y 1.64%
Sanofi Consumer Healthcare India Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Sanofi Consumer Healthcare India Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sanofi Consumer Healthcare India Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -1.08%
1M -3.11%
3M -0.05%
1Y -12.48%
YTD -1.20%
Sanofi Consumer Healthcare India Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Sanofi Consumer Healthcare India Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 3949.00
Day Before Yesterday 1326.00
1W Avg 12822.40
1M Avg 16138.14
3M Avg 10657.25
Sanofi Consumer Healthcare India Ltd Technical Details
Sanofi Consumer Healthcare India Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 4521
Support 2 4476
Support 3 4446
Pivot Point : 4551
Resistance 1 4596
Resistance 2 4625
Resistance 3 4671
Sanofi Consumer Healthcare India Ltd Corporate Actions
Sanofi Consumer Healthcare India Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sanofi Consumer Healthcare India Ltd’s capital allocation strategies.
All
Ex-Date 19-Jun-2026 Type D Description 75.00/share@750.00% Record Date 19-Jun-2026 Ratio 750.00
Ex-Date 17-Apr-2025 Type D Description 55.00/share@550.00% Record Date 17-Apr-2025 Ratio 550.00
Dividends
Announcement Date 19-Jun-2026 Ex Dividend Date 19-Jun-2026 Dividend(%) 750
Announcement Date 17-Apr-2025 Ex Dividend Date 17-Apr-2025 Dividend(%) 550
Bonus
No Bonus has been declared by SANOFICONR
Splits
No Split has been declared by SANOFICONR
Others
Rights No Rights has been declared by SANOFICONR
Sanofi Consumer Healthcare India Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Sanofi Consumer Healthcare India Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sanofi Consumer Healthcare India Ltd's relative performance and valuation against major competitors.
Stock Name Procter & Gamble Health Ltd ₹6839.00 (+3.43%) M. Cap (Cr) 113.52 1 Yr Return (%) +20.13% P/E (TTM) 34.73 PB Ratio 21.64
Stock Name Akums Drugs & Pharmaceuticals Ltd ₹701.95 (+6.65%) M. Cap (Cr) 110.48 1 Yr Return (%) +24.96% P/E (TTM) 43.29 PB Ratio 3.33
Stock Name Blue Jet Healthcare Ltd ₹624.05 (+8.62%) M. Cap (Cr) 108.25 1 Yr Return (%) -31.56% P/E (TTM) 43.68 PB Ratio 7.96
Stock Name Sanofi Consumer Healthcare India Ltd ₹4566.70 (+1.34%) M. Cap (Cr) 105.17 1 Yr Return (%) -12.48% P/E (TTM) 40.78 PB Ratio 27.39
Stock Name Strides Pharma Science Ltd ₹1082.60 (+0.61%) M. Cap (Cr) 99.79 1 Yr Return (%) +24.05% P/E (TTM) 17.94 PB Ratio 3.21
Stock Name Sudeep Pharma Ltd ₹824.25 (+2.74%) M. Cap (Cr) 93.10 1 Yr Return (%) NaN% P/E (TTM) 53.85 PB Ratio 10.54
Stock Name Sun Pharma Advanced Research Company Ltd ₹264.60 (-4.67%) M. Cap (Cr) 85.87 1 Yr Return (%) +67.42% P/E (TTM) 5.53 PB Ratio 6.41
Sanofi Consumer Healthcare India Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Sanofi Consumer Healthcare India Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Dec 2025 174.80 Dec 2024 439.00 Mar 2024 -0.40 Dec 2023 -0.40 Mar 2023 -0.40
PARTICULARS Investing Activities Dec 2025 7.60 Dec 2024 1.90 Mar 2024 0.00 Dec 2023 0.00 Mar 2023 0.00
PARTICULARS Financing Activities Dec 2025 -134.50 Dec 2024 -115.60 Mar 2024 0.00 Dec 2023 2.00 Mar 2023 2.00
PARTICULARS Net Cash Flow Dec 2025 47.90 Dec 2024 325.30 Mar 2024 -0.40 Dec 2023 1.60 Mar 2023 1.60
Sanofi Consumer Healthcare India Ltd Shareholding Pattern
This shows the ownership breakdown of Sanofi Consumer Healthcare India Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 71.27%
Public 8.41%
Other Institutions 3.94%
FII 2.76%
Mutual Funds 13.63%
About Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business. This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity. The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company.Pursuant to the Scheme, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger process. The demerger was strategically undertaken to facilitate independent and focused management for both businesses, enhance operational efficiency, provide greater transparency for stakeholders, and unlock shareholder value. The effective date of the Scheme was June 1, 2023. As per the Scheme, eligible shareholders of SIL received one fully paid-up equity share of the Company for every share they held in SIL on June 13, 2024.The Clayton, Dubilier & Rice group (CD&R Group) acquired majority control over Opal Bidco SAS and, has exercised ultimate indirect control over the Company in FY25.
Chairman & Independent Directo
Amit Jain
Registered office 3rd Floor Sanofi House CTS, 117-B L&T Business Park Powai, Mumbai, Maharashtra, 400072
FAX :91-22-2803 2000
Background
Incorporation Year 2023
Face Value ₹10.00
Market Lot 1
FAQs on Sanofi Consumer Healthcare India Ltd
How to buy Sanofi Consumer Healthcare India Ltd shares?
To buy Sanofi Consumer Healthcare India Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Sanofi Consumer Healthcare India Ltd?
The company has a market capitalization of ₹10,517.39.
What is the PE & PB ratio of Sanofi Consumer Healthcare India Ltd?
PE is 41 and PB is N/A.
What is the Sanofi Consumer Healthcare India Ltd dividend for 2025–26?
For the 2025–26 financial year, Sanofi Consumer Healthcare India Ltd declared a final dividend of 1.64% per share.